Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: Post hoc analysis of study COU-AA-302 Academic Article uri icon

Overview

MeSH Major

  • Abiraterone Acetate
  • Antineoplastic Agents, Hormonal
  • Antineoplastic Combined Chemotherapy Protocols
  • Bone Density Conservation Agents
  • Bone Neoplasms
  • Prostatic Neoplasms, Castration-Resistant
  • Steroid Synthesis Inhibitors

abstract

  • ClinicalTrials.gov NCT00887198.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5056561

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2015.04.032

PubMed ID

  • 25985882

Additional Document Info

start page

  • 570

end page

  • 7

volume

  • 68

number

  • 4